US Stock MarketDetailed Quotes

CALT Calliditas Therapeutics

Watchlist
  • 38.190
  • +0.040+0.10%
Close Jul 26 16:00 ET
  • 37.000
  • -1.190-3.12%
Post 20:01 ET
1.02BMarket Cap-21134P/E (TTM)

Calliditas Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Calliditas Therapeutics Earnings Date

Currency: SEK

Period

Q1 FY2024 Earnings

May 23, 2024

Revenue(YoY)

295.48M

+54.42%
EPS(YoY)

-9.18

-31.52%
Analyst Rating

Hold

Jul 27, 2024

Calliditas Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: SEK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 11, 20242024/Q3-- / 515.832M--
Aug 13, 20242024/Q2-- / 459.011M--
May 23, 20242024/Q1295.481M / 382.765M--
Feb 21, 20242023/Q4451.561M / 386.482M--
Nov 7, 20232023/Q3294.592M / 330.581M--
DatePeriodRevenue/EstimateEarnings Call
Nov 11, 20242024/Q3-- / 515.832M--
Aug 13, 20242024/Q2-- / 459.011M--
May 23, 20242024/Q1295.481M / 382.765M--
Feb 21, 20242023/Q4451.561M / 386.482M--
Nov 7, 20232023/Q3294.592M / 330.581M--

Unlock Free Earnings Estimates

Calliditas Therapeutics Earnings Reports

  • Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 23 16:28 ET

  • Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 25 16:11 ET

  • Calliditas Therapeutics | 20-F: Registration statement / Annual report / Transition report

    Apr 24 22:20 ET

  • Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Feb 21 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 27, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg